What is the best course of action for a 47-year-old male with a 5-year history of overactive bladder (OAB) symptoms, including frequent urine urge, currently taking Myrbetriq (mirabegron) 50, who also experiences occasional scrotum pain and dysuria (painful urination) after ejaculation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Your symptoms—post-ejaculatory burning, dysuria, scrotal pain, and worsening urinary urgency after ejaculation—strongly suggest chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) rather than simple overactive bladder, and you need urological evaluation with specific focus on prostate inflammation and pelvic floor dysfunction before continuing Myrbetriq alone. 1

Why This Isn't Just OAB

Your symptom pattern reveals critical red flags that distinguish this from typical overactive bladder:

  • Post-ejaculatory pain syndrome: The burning with urination and increased urgency specifically after ejaculation, combined with scrotal pain, is pathognomonic for prostatic/pelvic floor involvement, not bladder dysfunction alone 1

  • Intermittent flaring pattern: The "comes and goes" nature over 5 years with occasional scrotal pain suggests chronic inflammatory or pelvic floor muscle dysfunction rather than progressive bladder pathology 1

  • Incomplete response to beta-3 agonist: While Myrbetriq 50mg effectively treats pure OAB in men, your persistent symptoms despite treatment indicate an alternative or additional diagnosis 2, 3

Immediate Diagnostic Steps Required

Before any treatment modification, you need:

  • Post-void residual measurement: Essential to exclude urinary retention or incomplete emptying from prostatic obstruction, which would contraindicate continuing antimuscarinic therapy if added later (PVR >250-300 mL requires extreme caution) 1, 4

  • Urinalysis and urine culture: Must exclude occult urinary tract infection or prostatitis, as infection mimics and exacerbates both OAB and CP/CPPS symptoms 1

  • Digital rectal examination: Assess for prostatic tenderness, nodularity, or asymmetry that would indicate prostatitis or other prostatic pathology 1

  • Prostate-specific symptom assessment: Use NIH Chronic Prostatitis Symptom Index (NIH-CPSI) to quantify pain, urinary symptoms, and quality of life impact specific to prostatitis 1

Treatment Algorithm Based on Findings

If CP/CPPS is Confirmed (Most Likely):

  • Pelvic floor physical therapy: First-line treatment for CP/CPPS with pelvic floor muscle dysfunction, addressing the myofascial trigger points causing post-ejaculatory pain and urinary symptoms 1

  • Alpha-blocker therapy: Add tamsulosin or alfuzosin to your current Myrbetriq, as alpha-blockers specifically address prostatic/bladder neck dysfunction contributing to both voiding and storage symptoms in men with CP/CPPS 5, 3

  • Anti-inflammatory therapy: NSAIDs during symptomatic flares can reduce prostatic inflammation driving your cyclical symptoms 1

  • Continue Myrbetriq 50mg: The beta-3 agonist remains appropriate for the OAB component of your symptoms and is safe in combination with alpha-blockers 5, 3

If Pure OAB with Inadequate Control:

  • Optimize behavioral therapies first: Before medication escalation, implement timed voiding (every 2-3 hours), caffeine/alcohol elimination, and fluid management (25% reduction in total intake, especially evening restriction) 6, 1

  • Consider dose escalation: Myrbetriq can be increased to 100mg daily if 50mg provides insufficient symptom control after 8-12 weeks, though this is less likely your primary issue given the post-ejaculatory pattern 2, 7

  • Add antimuscarinic therapy: Combination of Myrbetriq 50mg plus low-dose solifenacin 5mg provides superior efficacy to monotherapy, but requires confirmed PVR <250 mL first 8, 1

Critical Pitfalls to Avoid

  • Do not add antimuscarinic medications without measuring PVR: If you have occult urinary retention from prostatic obstruction, antimuscarinics will worsen retention and potentially cause acute urinary retention requiring catheterization 6, 1

  • Do not dismiss the post-ejaculatory pattern: This specific symptom timing is the diagnostic key—pure OAB does not worsen specifically after ejaculation, while CP/CPPS characteristically does 1

  • Do not continue current therapy unchanged: Five years of intermittent symptoms without complete resolution indicates your current approach is inadequate and requires diagnostic refinement 1

Specialist Referral Threshold

You should be evaluated by a urologist now because: 6, 1

  • You have failed to achieve adequate symptom control with first-line behavioral therapy and second-line pharmacotherapy over 5 years
  • Your symptom pattern (post-ejaculatory pain, scrotal pain, dysuria) suggests pathology beyond simple OAB requiring specialized evaluation
  • Third-line therapies (sacral neuromodulation, peripheral tibial nerve stimulation, intradetrusor botulinum toxin) may be appropriate if combined medical management fails, but require comprehensive urological assessment first

References

Guideline

Overactive Bladder Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment Options for Overactive Bladder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mirabegron for male lower urinary tract symptoms.

Current urology reports, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can a patient with a history of overactive bladder and recurrent urinary tract infections (UTIs) resume taking Myrbetriq (mirabegron) after it was previously stopped due to UTI-related concerns?
What alternative medications, such as Myrbetriq (mirabegron), can be considered for a 57-year-old male with overactive bladder (OAB) symptoms, currently on Gemtesa (vibegron) and oxybutynin (oxybutynin chloride), with minimal improvement?
What is the best treatment option for a 68-year-old male with a history of nephrolithiasis (kidney stones) and symptoms of urinary frequency, urgency, and nocturia, who has previously shown improvement with Flomax (tamsulosin)?
At what time does Mirabegron (beta-3 adrenergic agonist) initiate its action in an adult patient with overactive bladder?
What is the best non alpha (alpha) blocker for urinary bladder relaxation?
How to manage a 22-year-old patient with Attention Deficit Hyperactivity Disorder (ADHD) and daily cannabis use, who is experiencing sleepiness and inadequate response to Lisdexamfetamine (dextroamphetamine and l-lysine mixture) 30 mg daily?
What are the implications and next steps for a 73-year-old male patient, 5 feet 8 inches tall, weighing 252 pounds, with an elevated C-peptide level of 2.67 ng/mL, normal fasting glucose, normal eGFR (estimated Glomerular Filtration Rate), normal creatinine, and an insulin resistance score of 46, considering his risk for developing type 2 diabetes and cardiovascular disease?
What is the appropriate management for a patient with an elevated Immunoglobulin E (IgE) level of 714 IU/mL?
Is paroxetine (selective serotonin reuptake inhibitor) a suitable treatment option for an 18-year-old female patient with potential porn addiction and possible comorbid depression or anxiety?
What is the appropriate management for a patient presenting with tender lymphadenopathy in the posterior neck and parotid gland?
What is gross pathology, is it bacteria visible to the naked eye?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.